In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K/A | 10-K | 10-K |
Revenues: |
Legacy YOD | | | | | 0.8 | 4.5 | | |
Wecast Services | | | | | 143.6 | 30.6 | | |
The United States of America (USA) | | | | | 0.0 | | | |
Total revenues | 114.1 | 26.8 | 44.6 | 377.7 | 144.4 | 35.2 | 4.6 | 2.0 |
Revenue growth [+] | 326.3% | -40.0% | -88.2% | 161.7% | 310.3% | 663.8% | 134.7% | 535.8% |
Legacy YOD | | | | | -82.5% | | | |
Wecast Services | | | | | 368.5% | | | |
Cost of goods sold | 90.9 | 24.7 | 1.5 | 244.1 | 137.2 | 35.6 | 3.7 | 2.8 |
Gross profit | 23.2 | 2.1 | 43.1 | 133.6 | 7.2 | -0.4 | 0.9 | -0.8 |
Gross margin | 20.4% | 7.7% | 96.7% | 35.4% | 5.0% | -1.0% | 20.2% | -40.4% |
Selling, general and administrative [+] | 107.5 | 44.9 | 30.7 | 27.2 | 16.3 | 12.3 | 9.0 | 8.1 |
Sales and marketing | 72.8 | 32.4 | 24.9 | 22.5 | 13.1 | 10.9 | 8.2 | |
General and administrative | 34.7 | 12.5 | 5.8 | 4.7 | 3.2 | 1.4 | 0.7 | |
Other selling, general and administrative | 72.8 | 32.4 | 24.9 | 22.5 | 13.1 | 10.9 | 8.2 | |
Research and development | 0.8 | 1.6 | | 1.7 | 0.4 | | | |
Equity in earnings | | | | -0.2 | -0.1 | 0.0 | -0.2 | 0.0 |
Other operating expenses | -13.9 | -20.5 | -66.8 | 131.6 | | 13.7 | | |
EBITDA [+] | -71.2 | -24.0 | 79.2 | -27.1 | -9.7 | -26.4 | -8.2 | -8.9 |
EBITDA growth | 196.3% | -130.3% | -392.6% | 179.0% | -63.2% | 222.8% | -8.4% | -13.2% |
EBITDA margin | -62.4% | -89.8% | 177.8% | -7.2% | -6.7% | -75.0% | -177.5% | -454.9% |
Depreciation | 0.6 | 0.1 | 0.1 | 0.3 | 0.3 | 0.5 | 0.2 | 0.5 |
EBITA | -71.8 | -24.1 | 79.1 | -27.3 | -10.0 | -26.9 | -8.4 | -9.5 |
EBITA margin | -62.9% | -90.2% | 177.5% | -7.2% | -6.9% | -76.5% | -181.6% | -482.2% |
Amortization of intangibles | 5.5 | 5.2 | 2.1 | 0.1 | | | 0.2 | |
EBIT [+] | -77.3 | -29.3 | 77.0 | -27.4 | -10.0 | -26.9 | -8.6 | -9.5 |
EBIT growth | 163.5% | -138.1% | -380.7% | 174.0% | -62.8% | 214.0% | -9.5% | -20.5% |
EBIT margin | -67.7% | -109.6% | 172.8% | -7.3% | -6.9% | -76.5% | -186.0% | -482.2% |
Non-recurring items [+] | 182.3 | 66.3 | 145.6 | -1.0 | 0.2 | 2.0 | | |
Asset impairment | 186.4 | 71.8 | 140.5 | 0.1 | 0.2 | 2.0 | | |
Loss (gain) on sale of business | | | | -1.2 | | | | |
Unusual expense | -9.6 | -5.5 | 5.1 | | | | | |
Interest expense, net [+] | 0.6 | 16.0 | 5.6 | 0.8 | 0.1 | 0.3 | 0.1 | 2.4 |
Interest expense | 2.1 | 16.1 | 5.7 | 0.8 | 0.1 | 0.3 | 0.1 | 2.4 |
Interest income | 1.5 | 0.1 | 0.1 | | | | | |
Other income (expense), net [+] | 3.2 | 13.5 | -8.5 | -1.3 | -0.5 | 0.3 | 0.1 | -1.5 |
Impairment of equity method investments | | | | | | 0.0 | -0.2 | |
Gain (loss) on sale of assets | | | | -0.2 | | | | -0.6 |
Gain (loss) on debt retirement | 0.3 | 8.9 | -3.9 | | | | | |
Change in fair value of warrants | | | | | -0.1 | 0.3 | 0.2 | |
Other | 1.3 | 6.6 | -0.4 | -0.1 | -0.4 | 0.1 | 0.1 | -0.1 |
Pre-tax income | -257.0 | -98.1 | -82.7 | -28.5 | -10.9 | -28.8 | -8.6 | -13.3 |
Income taxes | 11.8 | 3.3 | -0.4 | 0.0 | -0.4 | -0.3 | 0.0 | 0.3 |
Tax rate | | | 0.5% | 0.1% | 3.3% | 1.1% | 0.4% | |
Minority interest | -0.7 | 10.5 | -0.9 | -1.0 | -0.4 | -2.1 | -0.4 | 0.6 |
Net income | -256.7 | -111.8 | -97.7 | -28.4 | -10.5 | -26.4 | -8.1 | -28.8 |
Net margin | -225.0% | -417.7% | -219.1% | -7.5% | -7.3% | -75.1% | -175.9% | -1468.0% |
|
Basic EPS [+] | ($0.57) | ($0.52) | ($0.82) | ($0.36) | ($0.17) | ($0.73) | ($0.34) | ($1.47) |
Growth | 9.5% | -35.8% | 124.9% | 111.2% | -76.6% | 116.9% | -77.0% | 66.5% |
Diluted EPS [+] | ($0.57) | ($0.52) | ($0.82) | ($0.36) | ($0.17) | ($0.73) | ($0.34) | ($1.47) |
Growth | 9.5% | -35.8% | 124.9% | 111.2% | -76.6% | 116.9% | -77.0% | 66.5% |
|
Shares outstanding (basic) [+] | 447.8 | 213.5 | 119.8 | 78.4 | 61.2 | 36.0 | 23.9 | 19.6 |
Growth | 109.8% | 78.3% | 52.8% | 28.1% | 70.0% | 50.3% | 22.2% | 28.7% |
Shares outstanding (diluted) [+] | 447.8 | 213.5 | 119.8 | 78.4 | 61.2 | 36.0 | 23.9 | 19.6 |
Growth | 109.8% | 78.3% | 52.8% | 28.1% | 70.0% | 50.3% | 22.2% | 28.7% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |